A detailed history of Silverarc Capital Management, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,099,490 shares of ORIC stock, worth $9.18 Million. This represents 2.8% of its overall portfolio holdings.

Number of Shares
1,099,490
Previous 1,075,812 2.2%
Holding current value
$9.18 Million
Previous $7.61 Million 48.18%
% of portfolio
2.8%
Previous 2.16%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $11.9 $178,058 - $281,768
23,678 Added 2.2%
1,099,490 $11.3 Million
Q2 2024

Aug 14, 2024

SELL
$6.63 - $12.93 $246,602 - $480,931
-37,195 Reduced 3.34%
1,075,812 $7.61 Million
Q1 2024

May 14, 2024

SELL
$8.04 - $16.03 $458,223 - $913,597
-56,993 Reduced 4.87%
1,113,007 $15.3 Million
Q4 2023

Feb 14, 2024

BUY
$5.41 - $9.43 $252,403 - $439,956
46,655 Added 4.15%
1,170,000 $10.8 Million
Q3 2023

Nov 13, 2023

SELL
$6.05 - $9.28 $1.98 Million - $3.04 Million
-327,477 Reduced 22.57%
1,123,345 $6.8 Million
Q2 2023

Aug 14, 2023

BUY
$4.95 - $8.4 $73,641 - $124,966
14,877 Added 1.04%
1,450,822 $11.3 Million
Q1 2023

May 15, 2023

BUY
$4.26 - $6.75 $850,504 - $1.35 Million
199,649 Added 16.15%
1,435,945 $8.18 Million
Q4 2022

Feb 14, 2023

BUY
$2.41 - $5.89 $65,802 - $160,820
27,304 Added 2.26%
1,236,296 $7.28 Million
Q3 2022

Oct 28, 2022

BUY
$3.15 - $5.24 $399,067 - $663,845
126,688 Added 11.71%
1,208,992 $3.87 Million
Q2 2022

Jul 25, 2022

BUY
$2.7 - $7.07 $2.92 Million - $7.65 Million
1,082,304 New
1,082,304 $4.85 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $330M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.